Baxter International Inc.
BAXNYSEHealthcare● Active
$19.38
+$0.03(+0.16%)
Market Cap$10.0B
P/E Ratio—
52W High$32.04
52W Low$15.73
Baxter International Inc. (BAX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BAX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.36
Est. $0.31 · +16.1%
Revenue
$2.70B
Est. $2.62B · +3.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
BAX reports quarterly as a NYSE-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $0.37 | — | — | — | $2.80B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $0.31 | $0.36 | +16.1% | $2.70B | $2.62B | +3.3% |
| ▼ Q1 FY2026 | Feb 12, 2026 | $0.53 | $0.44 | -17.0% | $2.97B | $2.82B | +5.3% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $0.60 | $0.69 | +15.0% | $2.83B | $2.82B | +0.4% |
| ▼ Q3 FY2025 | Jul 31, 2025 | $0.60 | $0.59 | -1.7% | $2.81B | $2.88B | -2.3% |
| ▲ Q2 FY2025 | May 1, 2025 | $0.48 | $0.55 | +13.8% | $2.63B | $2.59B | +1.4% |
| ▲ Q1 FY2025 | Feb 20, 2025 | $0.53 | $0.58 | +9.8% | $2.75B | $2.67B | +3.0% |
| ▲ Q4 FY2024 | Nov 8, 2024 | $0.78 | $0.80 | +2.6% | $2.70B | $3.85B | -29.8% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$0.37
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$0.36
EPS Est.
$0.31
EPS Surpr.
+16.1%
Revenue
$2.70B
Q1 FY2026
Feb 12, 2026Miss
EPS Actual
$0.44
EPS Est.
$0.53
EPS Surpr.
-17.0%
Revenue
$2.97B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$0.69
EPS Est.
$0.60
EPS Surpr.
+15.0%
Revenue
$2.83B
Q3 FY2025
Jul 31, 2025Miss
EPS Actual
$0.59
EPS Est.
$0.60
EPS Surpr.
-1.7%
Revenue
$2.81B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$0.55
EPS Est.
$0.48
EPS Surpr.
+13.8%
Revenue
$2.63B
Q1 FY2025
Feb 20, 2025Beat
EPS Actual
$0.58
EPS Est.
$0.53
EPS Surpr.
+9.8%
Revenue
$2.75B
Q4 FY2024
Nov 8, 2024Beat
EPS Actual
$0.80
EPS Est.
$0.78
EPS Surpr.
+2.6%
Revenue
$2.70B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.81 | $0.82 | $0.84 | 4 |
| Q3 FY2028 | $0.75 | $0.76 | $0.77 | 6 |
| Q2 FY2028 | $0.77 | $0.78 | $0.79 | 4 |
| Q1 FY2028 | $0.64 | $0.65 | $0.66 | 4 |
| Q4 FY2027 | $0.59 | $0.60 | $0.61 | 3 |
| Q3 FY2027 | $0.51 | $0.52 | $0.52 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $3.1B | $3.1B | $3.2B | 6 |
| Q3 FY2028 | $3.0B | $3.0B | $3.1B | 3 |
| Q2 FY2028 | $2.9B | $3.0B | $3.0B | 5 |
| Q1 FY2028 | $2.7B | $2.7B | $2.8B | 3 |
| Q4 FY2027 | $3.0B | $3.1B | $3.1B | 7 |
| Q3 FY2027 | $2.9B | $2.9B | $2.9B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +16.1% | $16.90 | $17.58 | +4.02% |
| ▼ Q1 FY2026 | Feb 12, 2026 | -17.0% | $22.28 | $18.71 | -16.02% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +15.0% | $22.42 | $19.16 | -14.54% |
| ▼ Q3 FY2025 | Jul 31, 2025 | -1.7% | $28.05 | $21.76 | -22.42% |
| ▲ Q2 FY2025 | May 1, 2025 | +13.8% | $31.17 | $30.67 | -1.60% |
| ▲ Q1 FY2025 | Feb 20, 2025 | +9.8% | $30.82 | $33.44 | +8.50% |
| ▲ Q4 FY2024 | Nov 8, 2024 | +2.6% | $36.04 | $34.64 | -3.88% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +2.7% | $34.64 | $36.92 | +6.58% |
Q2 FY2026+4.02%
Report Date
Apr 30, 2026
EPS Beat/Miss
+16.1%
Price Before
$16.90
Price After
$17.58
Q1 FY2026-16.02%
Report Date
Feb 12, 2026
EPS Beat/Miss
-17.0%
Price Before
$22.28
Price After
$18.71
Q4 FY2025-14.54%
Report Date
Oct 30, 2025
EPS Beat/Miss
+15.0%
Price Before
$22.42
Price After
$19.16
Q3 FY2025-22.42%
Report Date
Jul 31, 2025
EPS Beat/Miss
-1.7%
Price Before
$28.05
Price After
$21.76
Q2 FY2025-1.60%
Report Date
May 1, 2025
EPS Beat/Miss
+13.8%
Price Before
$31.17
Price After
$30.67
Q1 FY2025+8.50%
Report Date
Feb 20, 2025
EPS Beat/Miss
+9.8%
Price Before
$30.82
Price After
$33.44
Q4 FY2024-3.88%
Report Date
Nov 8, 2024
EPS Beat/Miss
+2.6%
Price Before
$36.04
Price After
$34.64
Q3 FY2024+6.58%
Report Date
Aug 6, 2024
EPS Beat/Miss
+2.7%
Price Before
$34.64
Price After
$36.92
Avg Beat Reaction-0.15%
Avg Miss Reaction-19.22%
Beat Rate6 / 8 quarters
Largest Move-22.42% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BAX ends December
Baxter International Inc. (BAX) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.36 — beating the analyst consensus of $0.31 by +16.1%. The next BAX earnings date is expected around September 1, 2026.
Each quarter, investors track BAX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BAX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BAX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BAX earnings · 5 questionsBaxter International Inc.'s next earnings report is expected around September 1, 2026. BAX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BAX historically reports after market close (AMC).
BAX earnings datewhen is BAX earningsBAX next earnings datewhen does BAX report earningsBAX earnings calendar
▸ Source: FMP · Baxter International Inc. SEC filings · US GAAP · Baxter International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026